13.3 Neuraxial Anticoagulation Guidelines (ASRA) & Epidural Hematoma
Key Takeaways
- The American Society of Regional Anesthesia and Pain Medicine (ASRA) guidelines establish strict withholding intervals for neuraxial instrumentation and catheter manipulation/removal to prevent catastrophic spinal epidural hematoma.
- Unfractionated Heparin (UFH): Subcutaneous prophylaxis (5000 U bid/tid) requires no mandatory hold time; therapeutic IV heparin requires a 4-6 hour hold with documentation of normal aPTT before puncture/removal, and waiting ≥1 hour after puncture before systemic heparin administration.
- Low Molecular Weight Heparin (LMWH): Prophylactic dosing (e.g. Enoxaparin 40 mg daily) mandates a 12-hour hold prior to puncture/catheter removal; therapeutic dosing (e.g. Enoxaparin 1 mg/kg q12h) mandates a 24-hour hold; restart LMWH ≥4 hours after catheter removal.
- Direct Oral Anticoagulants (DOACs) require holding Rivaroxaban/Apixaban for 72 hours and Dabigatran for 72-120 hours; Warfarin requires holding for 5 days with documentation of a normal INR (<1.4-1.5); Clopidogrel requires a 5-7 day hold, whereas Aspirin alone requires no discontinuation.
- Spinal Epidural Hematoma (SEH) is a surgical emergency presenting with sharp back pain, motor/sensory block progression, and bowel/bladder dysfunction; emergent MRI and decompressive laminectomy within 6 to 8 hours of symptom onset is mandatory to prevent permanent, irreversible paraplegia.
13.3 Neuraxial Anticoagulation Guidelines (ASRA) & Epidural Hematoma
Performing neuraxial procedures in the presence of altered hemostasis introduces the catastrophic risk of Spinal Epidural Hematoma (SEH). Because the vertebral canal is a rigid, non-distensible bony ring, an expanding hematoma compresses spinal cord blood flow and neural tissue, causing permanent ischemic paraplegia unless surgically decompressed within hours. Strict adherence to the American Society of Regional Anesthesia and Pain Medicine (ASRA) anticoagulation guidelines is mandatory.
1. ASRA Anticoagulation Consensus Guidelines: Comprehensive Matrix
+---------------------------------------------------------------------------------------------------------+
| ASRA NEURAXIAL ANTICOAGULATION GUIDELINES |
+-----------------------+-----------------------------+-----------------------------+---------------------+
| Drug Class & Name | Pre-Procedure Discontinuation| Catheter Removal Timing | Post-Removal Restart|
| | (Hold Time Before Puncture) | (Hold Time Before Pulling) | (Wait Time to Dose) |
+-----------------------+-----------------------------+-----------------------------+---------------------+
| **SubQ UFH Prophylaxis| **No mandatory delay** | **No mandatory delay** | May dose immediately|
| (5,000 U bid or tid) | (Check platelets if >4 days)| (Avoid pulling at peak 2h) | after catheter pull |
+-----------------------+-----------------------------+-----------------------------+---------------------+
| **IV Heparin** | **4 - 6 hours** | **4 - 6 hours** | **≥ 1 hour** |
| (Therapeutic Infusion)| + Document NORMAL aPTT/ACT | + Document NORMAL aPTT/ACT | (Wait ≥1h post-op) |
+-----------------------+-----------------------------+-----------------------------+---------------------+
| **LMWH Prophylactic** | **12 hours** | **12 hours** | **≥ 4 hours** |
| (Enoxaparin 40 mg q24h| (Enoxaparin, Dalteparin) | (Delay dose until removed) | |
+-----------------------+-----------------------------+-----------------------------+---------------------+
| **LMWH Therapeutic** | **24 hours** | **24 hours** | **≥ 4 hours** |
| (Enoxaparin 1 mg/kg) | (Full treatment dose) | (No indwelling cath with bid)| (≥24h if major surg)|
+-----------------------+-----------------------------+-----------------------------+---------------------+
| **Warfarin** | **5 days** | **Document INR < 1.4 - 1.5**| Immediate post-pull |
| (Coumadin) | + Document INR < 1.4 - 1.5 | before pulling catheter | |
+-----------------------+-----------------------------+-----------------------------+---------------------+
| **Rivaroxaban / | **72 hours** (3 days) | **72 hours** | **≥ 6 hours** |
| Apixaban (Xa Inh)** | | | |
+-----------------------+-----------------------------+-----------------------------+---------------------+
| **Dabigatran** | **72 hours** (CrCl ≥ 50) | **72 hours** (CrCl ≥ 50) | **≥ 6 hours** |
| (Direct Thrombin Inh) | **120 hours** (CrCl 30-49) | **120 hours** (CrCl 30-49) | |
+-----------------------+-----------------------------+-----------------------------+---------------------+
| **Clopidogrel** | **5 - 7 days** | **5 - 7 days** | Immediate (no load);|
| (Plavix - P2Y12) | (5 days minimum) | | ≥6h if 300-600mg ld |
+-----------------------+-----------------------------+-----------------------------+---------------------+
| **Prasugrel** (Effient)| **7 - 10 days** | **7 - 10 days** | **≥ 6 hours** |
| **Ticagrelor**(Brilinta)| **3 - 5 days** | **3 - 5 days** | **≥ 6 hours** |
+-----------------------+-----------------------------+-----------------------------+---------------------+
| **Aspirin / NSAIDs** | **NO mandatory hold** | **NO mandatory hold** | No restriction |
| (Monotherapy) | (Safe as single agent) | (Safe as single agent) | |
+-----------------------+-----------------------------+-----------------------------+---------------------+
| **GP IIb/IIIa Inh** | • Abciximab: **24-48 hrs** | • Abciximab: **24-48 hrs** | Immediate post-pull |
| | • Eptifibatide: **4-8 hrs** | • Eptifibatide: **4-8 hrs** | |
+-----------------------+-----------------------------+-----------------------------+---------------------+
| **Thrombolytics** | **10 days** | **10 days** | Absolute contraindic|
| (tPA, Alteplase) | | | during infusion |
+-----------------------+-----------------------------+-----------------------------+---------------------+
| **Herbal Supplements**| **NO mandatory hold** | **NO mandatory hold** | No restriction |
| (Garlic, Ginkgo, Gins)| (Monitor if combined) | (Monitor if combined) | |
+-----------------------+-----------------------------+-----------------------------+---------------------+
Special Clinical Scenarios in Neuraxial Anticoagulation
- Intraoperative Systemic Heparinization (e.g., Vascular / Cardiac Surgery):
- Neuraxial needle placement or catheter insertion must occur at least $\ge 1 \text{ hour}$ before systemic heparin administration.
- If a bloody or traumatic tap occurs, consider postponing surgery for $24 \text{ hours}$; if surgery cannot be delayed, monitor postoperative neurological status with extreme vigilance.
- Warfarin Initiated with Indwelling Epidural Catheter:
- Monitor INR daily. Catheter removal is permitted when $\text{INR} < 1.4 - 1.5$.
- If the INR is $1.5 - 3.0$, withhold warfarin and conduct hourly neurologic exams until INR declines below $1.4$.
- If the INR $>3.0$, withhold warfarin, reverse with Vitamin K or Prothrombin Complex Concentrate (PCC) if emergent removal is required.
2. Spinal Epidural Hematoma (SEH): Etiology & Pathophysiology
[SPINAL EPIDURAL HEMATOMA PATHOGENESIS]
Needle / Catheter Trauma to Batson's Internal Venous Plexus
|
v
Impaired Hemostasis / Peak Anticoagulant Pharmacokinetics
|
v
Expanding Space-Occupying Mass in Rigid Bony Spinal Canal
|
v
Tissue Pressure Exceeds Spinal Cord Venous & Capillary Pressure
|
+--------------------------+--------------------------+
| |
v v
Direct Mechanical Neural Compression Spinal Cord Ischemia & Necrosis
• Cauda equina root flattening • Anterior spinal artery hypoperfusion
• Flaccid lower motor neuron paralysis • Venous infarction of spinal cord
| |
+--------------------------+--------------------------+
|
v
THE CLASSICAL CLINICAL TRIAD OF EPIDURAL HEMATOMA
1. Sharp, severe, unremitting back pain (± radicular pain)
2. Progressive motor weakness & sensory deficit (flaccid paraplegia)
3. Sphincter dysfunction (urinary retention & fecal incontinence)
Major Risk Factors for Spinal Epidural Hematoma
- Pharmacologic: Neuraxial instrumentation during peak anticoagulant effect, concurrent multi-agent anticoagulation (e.g., NSAID + LMWH + antiplatelet), or premature catheter removal.
- Patient Factors: Advanced age ($>65$ years), female gender, preexisting spinal canal stenosis, ankylosing spondylitis, severe scoliosis, chronic renal failure (drug accumulation).
- Procedural Factors: Multiple needle attempts, difficult/traumatic "bloody tap", large-bore needles (17G Tuohy), and catheter removal (which carries equal risk to initial catheter placement).
3. SEH Diagnostic Emergency & The Critical 6 to 8 Hour Window
+-------------------------------------------------------------------------+
| EPIDURAL HEMATOMA EMERGENCY ACTION PROTOCOL |
+-------------------------------------------------------------------------+
| |
| STEP 1: Immediate Clinical Recognition & Local Anesthetic Cessation |
| • Immediately STOP any epidural local anesthetic infusion |
| • Do NOT assume block prolongation is simply delayed drug clearance |
| • Perform immediate focused motor, sensory, and rectal sphincter exams|
| |
| STEP 2: STAT Diagnostic Imaging (Gold Standard) |
| • Order an **EMERGENT STAT MRI of the Spine** (without/with contrast) |
| • If MRI is contraindicated (pacemaker/metal), perform STAT CT |
| Myelography |
| |
| STEP 3: Emergent Neurosurgical / Spine Consultation |
| • Alert spine surgery team while the patient is en route to MRI |
| • Prepare patient for immediate operating room transfer |
| |
| STEP 4: Emergent Surgical Decompression (The 6-8 Hour Rule) |
| • Perform **Decompressive Laminectomy and Hematoma Evacuation** |
| • **Time Window: MUST occur within 6 to 8 hours of symptom onset** |
| • Decompression within 6-8 hrs yields >80-90% neurological recovery |
| • Decompression delayed >8-12 hrs results in permanent, irreversible |
| flaccid paraplegia and permanent loss of bowel/bladder control |
+-------------------------------------------------------------------------+
[SURGICAL DECOMPRESSION TIMELINE & OUTCOMES]
Neurologic
Recovery (%)
100 | /-------------------\
80 | / \
60 |/ \
40 | \
20 | \
0 +---------------------------+---------------------------+-----> Time to Laminectomy
0 6 12 (Hours)
<==== EXCELLENT RECOVERY ====> <== PERMANENT PARAPLEGIA ==>
(0 to 6-8 Hours) (>8 to 12 Hours)
4. Differential Diagnosis: Epidural Hematoma vs. Epidural Abscess
+-------------------------------------------------------------------------+
| EPIDURAL HEMATOMA vs. EPIDURAL ABSCESS vs. MENINGITIS |
+--------------------+------------------------+---------------------------+
| Clinical Domain | Spinal Epidural | Spinal Epidural |
| | Hematoma (SEH) | Abscess (SEA) |
+--------------------+------------------------+---------------------------+
| **Etiology** | Venous / arterial | Bacterial infection |
| | hemorrhage in canal | (*Staph aureus* 60-70%) |
| **Primary Risk** | Anticoagulants, | Prolonged catheter (>3d), |
| | coagulopathy, trauma | immunosuppression, sepsis |
| **Onset Speed** | **Hyperacute / Sudden**| **Subacute / Indolent** |
| | (Hours after block/pull| (2 to 7 days post-op) |
| **Temperature / | Afebrile; normal WBC | **Fever, severe chills, |
| Systemic Signs** | | leukocytosis, ↑ ESR / CRP |
| **Classical Signs**| Acute severe back pain,| 4 Stages: Backache → |
| | motor/sensory block, | Radicular pain → Motor/ |
| | bowel/bladder loss | sensory loss → Paraplegia |
| **Diagnostic Test**| STAT Spine MRI | STAT Spine MRI + Contrast |
| **Definitive Rx** | Emergent laminectomy | IV Vancomycin + Cefepime; |
| | within **6 - 8 hours** | Surgical drainage/decomp. |
+--------------------+------------------------+---------------------------+
NCE Board Golden Rule — Unexplained Motor Block Prolongation: Any motor or sensory block that worsens, ascends, or fails to regress within the expected pharmacologic duration of the administered local anesthetic is a Spinal Epidural Hematoma until proven otherwise. Never wait for full recovery or attribute findings to local anesthetic variability—stop infusions and obtain a STAT MRI immediately.
A 68-year-old female with an indwelling thoracic epidural catheter for post-thoracotomy analgesia is receiving therapeutic Low Molecular Weight Heparin (Enoxaparin 1 mg/kg subcutaneously every 12 hours) for an acute deep vein thrombosis. According to ASRA guidelines, what is the mandatory time interval before the epidural catheter can be safely removed, and when can the next dose of LMWH be administered?
A patient taking several home medications is scheduled for an elective total hip arthroplasty under spinal anesthesia. Which preoperative medication regimen and ASRA discontinuation schedule is correct?
Four hours following the removal of a lumbar epidural catheter in a patient receiving subcutaneous enoxaparin, the patient complains of sharp, severe low back pain radiating down both legs. Over the next hour, she develops progressive flaccid weakness in both lower extremities and urinary incontinence. What is the suspected diagnosis, the gold-standard diagnostic modality, and the critical time window for definitive intervention?
A patient undergoing an open abdominal aortic aneurysm (AAA) repair receives a thoracic epidural catheter for perioperative analgesia. Intraoperative systemic unfractionated heparin (5,000 units IV) is planned for aortic cross-clamping. What is the minimum recommended time delay between epidural needle/catheter placement and systemic heparin administration according to ASRA guidelines?